Author

Ying Hu

Institutions: University of California Davis Medical Center, UC Davis Health, University of California, Davis

Observed institutions: University of California Davis Medical Center, UC Davis Health, University of California, Davis

OpenAlex ID: A5044097708

miR-22 gene therapy treats HCC by promoting anti-tumor immunity and enhancing metabolism

2023 · Ying Hu, Tahereh Setayesh, et al. · Molecular Therapy · 44

Targeting stroma and tumor, silencing galectin 1 treats orthotopic mouse hepatocellular carcinoma

2023 · Tahereh Setayesh, Ying Hu, et al. · Acta Pharmaceutica Sinica B · 14

The spatial impact of a Western diet in enriching Galectin-1-regulated Rho, ECM, and SASP signaling in a novel MASH-HCC mouse model

2024 · Tahereh Setayesh, Ying Hu, et al. · Biomarker Research · 9

Multi-pathway targeted therapy of MASH-HCC using miR-22

2025 · Ying Hu, Tahereh Setayesh, et al. · Cell & Bioscience · 6

Works count: 4

Citation count: 73

H-index: 4

I10-index: 2